{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T17:51:45Z","timestamp":1760205105805,"version":"3.37.3"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Inform Decis Mak"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The Coronavirus Disease 2019 (COVID-19) pandemic has infected over 10 million people globally with a relatively high mortality rate. There are many therapeutics undergoing clinical trials, but there is no effective vaccine or therapy for treatment thus far. After affected by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), molecular signaling pathways of host cells play critical roles during the life cycle of SARS-CoV-2. Thus, it is significant to identify the involved molecular signaling pathways within the host cells. Drugs targeting these molecular signaling pathways could be potentially effective for COVID-19 treatment.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this study, we developed a novel integrative analysis approach to identify the related molecular signaling pathways within host cells, and repurposed drugs as potentially effective treatments for COVID-19, based on the transcriptional response of host cells.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We identified activated signaling pathways associated with the infection caused SARS-CoV-2 in human lung epithelial cells through integrative analysis. Then, the activated gene ontologies (GOs) and super GOs were identified. Signaling pathways and GOs such as MAPK, JNK, STAT, ERK, JAK-STAT, IRF7-NFkB signaling, and MYD88\/CXCR6 immune signaling were particularly activated. Based on the identified signaling pathways and GOs, a set of potentially effective drugs were repurposed by integrating the drug-target and reverse gene expression data resources. In addition to many drugs being evaluated in clinical trials, the <jats:italic>dexamethasone<\/jats:italic> was top-ranked in the prediction, which was the first reported drug to be able to significantly reduce the death rate of COVID-19 patients receiving respiratory support.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The integrative genomics data analysis and results can be helpful to understand the associated molecular signaling pathways within host cells, and facilitate the discovery of effective drugs for COVID-19 treatment.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12911-020-01373-x","type":"journal-article","created":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T17:03:50Z","timestamp":1610039030000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Computational analysis to repurpose drugs for COVID-19 based on transcriptional response of host cells to SARS-CoV-2"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3773-146X","authenticated-orcid":false,"given":"Fuhai","family":"Li","sequence":"first","affiliation":[]},{"given":"Andrew P.","family":"Michelson","sequence":"additional","affiliation":[]},{"given":"Randi","family":"Foraker","sequence":"additional","affiliation":[]},{"given":"Ming","family":"Zhan","sequence":"additional","affiliation":[]},{"given":"Philip R. O.","family":"Payne","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2021,1,7]]},"reference":[{"key":"1373_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30120-1","author":"E Dong","year":"2020","unstructured":"Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020. https:\/\/doi.org\/10.1016\/S1473-3099(20)30120-1.","journal-title":"Lancet Infect Dis"},{"key":"1373_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2196-x","author":"R W\u00f6lfel","year":"2020","unstructured":"W\u00f6lfel R, et al. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020. https:\/\/doi.org\/10.1038\/s41586-020-2196-x.","journal-title":"Nature"},{"key":"1373_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30243-7","author":"R Verity","year":"2020","unstructured":"Verity R, et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis. 2020. https:\/\/doi.org\/10.1016\/S1473-3099(20)30243-7.","journal-title":"Lancet Infect Dis"},{"key":"1373_CR4","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1126\/science.abb7498","volume":"80","author":"Y Gao","year":"2020","unstructured":"Gao Y, et al. Structure of the RNA-dependent RNA polymerase from COVID-19 virus. Science. 2020;80:779. https:\/\/doi.org\/10.1126\/science.abb7498.","journal-title":"Science"},{"key":"1373_CR5","doi-asserted-by":"publisher","unstructured":"Horby, P. et al. Effect of dexamethasone in hospitalized patients with COVID-19: preliminary report. medRxiv (2020). https:\/\/doi.org\/10.1101\/2020.06.22.20137273","DOI":"10.1101\/2020.06.22.20137273"},{"key":"1373_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/S2589-7500(20)30086-8","author":"K Thorlund","year":"2020","unstructured":"Thorlund K, et al. A real-time dashboard of clinical trials for COVID-19. Lancet Digit Heal. 2020. https:\/\/doi.org\/10.1016\/S2589-7500(20)30086-8.","journal-title":"Lancet Digit Heal"},{"key":"1373_CR7","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1093\/femspd\/ftaa036","volume":"78","author":"Z Jia","year":"2020","unstructured":"Jia Z, Song X, Shi J, Wang W, He K. Transcriptome-based drug repositioning for coronavirus disease 2019 (COVID-19). Pathog Dis. 2020;78:36.","journal-title":"Pathog Dis"},{"key":"1373_CR8","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1186\/s12864-016-2737-8","volume":"17","author":"Z Jia","year":"2016","unstructured":"Jia Z, et al. Cogena, a novel tool for co-expressed gene-set enrichment analysis, applied to drug repositioning and drug mode of action discovery. BMC Genomics. 2016;17:414.","journal-title":"BMC Genomics"},{"key":"1373_CR9","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.chom.2020.04.017","volume":"27","author":"Z Zhou","year":"2020","unstructured":"Zhou Z, et al. Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients. Cell Host Microbe. 2020;27:883-890.e2.","journal-title":"Cell Host Microbe"},{"key":"1373_CR10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/nar\/27.1.29","volume":"28","author":"H Ogata","year":"1999","unstructured":"Ogata H, et al. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 1999;28:29. https:\/\/doi.org\/10.1093\/nar\/27.1.29.","journal-title":"Nucleic Acids Res"},{"key":"1373_CR11","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 2019;28:1947\u201351.","journal-title":"Protein Sci"},{"key":"1373_CR12","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkaa970","author":"M Kanehisa","year":"2020","unstructured":"Kanehisa M, Furumichi M, Sato Y, Ishiguro-Watanabe M, Tanabe M. KEGG: integrating viruses and cellular organisms. Nucleic Acids Res. 2020. https:\/\/doi.org\/10.1093\/nar\/gkaa970.","journal-title":"Nucleic Acids Res"},{"key":"1373_CR13","doi-asserted-by":"publisher","first-page":"D691","DOI":"10.1093\/nar\/gkq1018","volume":"39","author":"D Croft","year":"2011","unstructured":"Croft D, et al. Reactome: a database of reactions, pathways and biological processes. Nucleic Acids Res. 2011;39:D691\u20137.","journal-title":"Nucleic Acids Res"},{"key":"1373_CR14","doi-asserted-by":"publisher","unstructured":"Blanco-Melo, D. et al. SARS-CoV-2 launches a unique transcriptional signature from in vitro, ex vivo, and in vivo systems. bioRxiv (2020). doi:https:\/\/doi.org\/10.1101\/2020.03.24.004655","DOI":"10.1101\/2020.03.24.004655"},{"key":"1373_CR15","doi-asserted-by":"publisher","unstructured":"Xu, J. et al. Diffusion mapping of drug targets on disease signaling network elements reveals drug combination strategies. in Proceedings of tpacific symposium on biocomputing 92\u2013103 (2018).https:\/\/doi.org\/10.1142\/9789813235533_0009","DOI":"10.1142\/9789813235533_0009"},{"key":"1373_CR16","unstructured":"Gene Ontology Consortium, T. et al. Gene ontology: tool for the unification of biology NIH public access author manuscript. Nat Genet 25, 25\u201329 (2000)."},{"key":"1373_CR17","doi-asserted-by":"crossref","unstructured":"Wishart, D. S. et al. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 46, D1074\u2013D1082 (2018).","DOI":"10.1093\/nar\/gkx1037"},{"key":"1373_CR18","unstructured":"Lamb, J. et al. The connectivity map: Using gene-expression signatures to connect small molecules, genes, and disease. Science (80-. ). 313, 1929\u20131935 (2006)."},{"key":"1373_CR19","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/j.cell.2017.10.049","volume":"171","author":"A Subramanian","year":"2017","unstructured":"Subramanian A, et al. A next generation connectivity map: L1000 platform and the first 1,000,000 profiles. Cell. 2017;171:1437\u201352.","journal-title":"Cell"},{"key":"1373_CR20","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41540-019-0085-4","volume":"5","author":"KE Regan-Fendt","year":"2019","unstructured":"Regan-Fendt KE, et al. Synergy from gene expression and network mining (SynGeNet) method predicts synergistic drug combinations for diverse melanoma genomic subtypes. Syst Biol Appl. 2019;5:6.","journal-title":"Syst Biol Appl"},{"key":"1373_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014. https:\/\/doi.org\/10.1186\/s13059-014-0550-8.","journal-title":"Genome Biol"},{"key":"1373_CR22","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1471-2105-13-20","volume":"13","author":"G Sales","year":"2012","unstructured":"Sales G, Calura E, Cavalieri D, Romualdi C. graphite - a Bioconductor package to convert pathway topology to gene network. BMC Bioinformatics. 2012;13:20.","journal-title":"BMC Bioinformatics"},{"key":"1373_CR23","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1093\/bioinformatics\/bty719","volume":"35","author":"G Sales","year":"2019","unstructured":"Sales G, Calura E, Romualdi C. metaGraphite-a new layer of pathway annotation to get metabolite networks. Bioinformatics. 2019;35:1258\u201360.","journal-title":"Bioinformatics"},{"key":"1373_CR24","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btq064","author":"G Yu","year":"2010","unstructured":"Yu G, et al. GOSemSim: An R package for measuring semantic similarity among GO terms and gene products. Bioinformatics. 2010. https:\/\/doi.org\/10.1093\/bioinformatics\/btq064.","journal-title":"Bioinformatics"},{"key":"1373_CR25","doi-asserted-by":"crossref","unstructured":"Frey, B. J. & Dueck, D. Clustering by passing messages between data points. Science (80-. ). 315, 972\u2013976 (2007).","DOI":"10.1126\/science.1136800"},{"key":"1373_CR26","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102:15545\u201350.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1373_CR27","unstructured":"Lim, Y. X., Ng, Y. L., Tam, J. P. & Liu, D. X. Human Coronaviruses: A Review of Virus-Host Interactions. Dis. (Basel, Switzerland) 4, 26 (2016)."},{"key":"1373_CR28","first-page":"e29","volume":"8","author":"A Rismanbaf","year":"2020","unstructured":"Rismanbaf A. Potential Treatments for COVID-19; a Narrative Literature Review. Arch Acad Emerg Med. 2020;8:e29\u2013e29.","journal-title":"Arch Acad Emerg Med"},{"issue":"20","key":"1373_CR29","doi-asserted-by":"publisher","first-page":"30858","DOI":"10.1016\/S0140-6736(20)30858-8","volume":"S0140\u20136736","author":"M Feldmann","year":"2020","unstructured":"Feldmann M, et al. Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed. Lancet (London, England). 2020;S0140\u20136736(20):30858\u201368. https:\/\/doi.org\/10.1016\/S0140-6736(20)30858-8.","journal-title":"Lancet (London, England)"},{"key":"1373_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30304-4","author":"P Richardson","year":"2020","unstructured":"Richardson P, et al. Baricitinib as potential treatment for 2019-nCoV acute respiratory disease. The Lancet. 2020. https:\/\/doi.org\/10.1016\/S0140-6736(20)30304-4.","journal-title":"The Lancet"},{"key":"1373_CR31","doi-asserted-by":"crossref","unstructured":"Luo, P. et al. Tocilizumab treatment in COVID-19: A single center experience. J. Med. Virol. n\/a, (2020).","DOI":"10.1002\/jmv.25801"},{"key":"1373_CR32","doi-asserted-by":"publisher","first-page":"104791","DOI":"10.1016\/j.antiviral.2020.104791","volume":"178","author":"E Sallard","year":"2020","unstructured":"Sallard E, Lescure F-X, Yazdanpanah Y, Mentre F, Peiffer-Smadja N. Type 1 interferons as a potential treatment against COVID-19. Antiviral Res. 2020;178:104791.","journal-title":"Antiviral Res"},{"key":"1373_CR33","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1002\/ptr.6776","volume":"34","author":"M Bahrami","year":"2020","unstructured":"Bahrami M, Kamalinejad M, Latifi SA, Seif F, Dadmehr M. Cytokine storm in COVID-19 and parthenolide: Preclinical evidence. Phytother Res. 2020;34:2429\u201330.","journal-title":"Phytother Res"},{"key":"1373_CR34","doi-asserted-by":"publisher","DOI":"10.3332\/ecancer.2020.1023","author":"B Russell","year":"2020","unstructured":"Russell B, Moss C, Rigg A, Van Hemelrijck M. COVID-19 and treatment with NSAIDs and corticosteroids: Should we be limiting their use in the clinical setting? Ecancermedicalscience. 2020. https:\/\/doi.org\/10.3332\/ecancer.2020.1023.","journal-title":"Ecancermedicalscience"},{"key":"1373_CR35","doi-asserted-by":"publisher","first-page":"e0196351","DOI":"10.1371\/journal.pone.0196351","volume":"13","author":"T Zhang","year":"2018","unstructured":"Zhang T, et al. Core signaling pathways in ovarian cancer stem cell revealed by integrative analysis of multi-marker genomics data. PLoS ONE. 2018;13:e0196351.","journal-title":"PLoS ONE"},{"key":"1373_CR36","doi-asserted-by":"crossref","unstructured":"Zhang, T., Zhang, L. & Li, F. Integrative network analysis identifies potential targets and drugs for ovarian cancer. IInternational Conf. Intell. Biol. Med. recommended for publication at BMC Medical Genomic (2019).","DOI":"10.1186\/s12920-020-00773-2"},{"key":"1373_CR37","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12918-017-0462-9","volume":"11","author":"H Wu","year":"2017","unstructured":"Wu H, et al. MD-Miner: A network-based approach for personalized drug repositioning. BMC Syst Biol. 2017;11:86.","journal-title":"BMC Syst Biol"},{"key":"1373_CR38","unstructured":"Regan, K. E., Payne, P. R. O. & Li, F. Integrative network and transcriptomics-based approach predicts genotype- specific drug combinations for melanoma. AMIA Jt. Summits Transl. Sci. proceedings. AMIA Jt. Summits Transl. Sci. 247\u2013256 (2017)."}],"container-title":["BMC Medical Informatics and Decision Making"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-020-01373-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12911-020-01373-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-020-01373-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T18:18:43Z","timestamp":1610043523000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedinformdecismak.biomedcentral.com\/articles\/10.1186\/s12911-020-01373-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,7]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1373"],"URL":"https:\/\/doi.org\/10.1186\/s12911-020-01373-x","relation":{},"ISSN":["1472-6947"],"issn-type":[{"type":"electronic","value":"1472-6947"}],"subject":[],"published":{"date-parts":[[2021,1,7]]},"assertion":[{"value":"15 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15"}}